Evrofarma SA (EVROF.AT)
EUR 1.63
(0.93%)
EUR 1.63
(0.93%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.14 Million | 2.64 Million | -805 Thousand | 1.45 Million | 1.62 Million | 2.29 Million |
| Net Income | 2.2 Million | 1.41 Million | -355 Thousand | 1.08 Million | 157 Thousand | 979 Thousand |
| Depreciation & Amortization | 1.7 Million | 1.54 Million | 1.44 Million | 1.39 Million | 1.43 Million | 1.36 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -856 Thousand | -93 Thousand | -1.59 Million | -657 Thousand | -1.25 Million | -156 Thousand |
| Other non-cash items | 92 Thousand | 2.94 Million | -297 Thousand | 3.08 Million | 5.41 Million | 2.99 Million |
| Investing Cash Flow | -2.01 Million | -1.33 Million | -3.26 Million | -806 Thousand | -700 Thousand | -983 Thousand |
| Investments in PPE | -2.6 Million | -2.05 Million | -3.34 Million | -904 Thousand | -718 Thousand | -993 Thousand |
| Acquisitions | - | 68 Thousand | - | - | 18 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 589 Thousand | 652 Thousand | 80 Thousand | 98 Thousand | 18 Thousand | 10 Thousand |
| Financing Cash Flow | -1.9 Million | -118 Thousand | 1.21 Million | 2.35 Million | -1.36 Million | -1.57 Million |
| Debt repayment | -1.9 Million | -66 Thousand | -1.21 Million | -2.4 Million | -1.31 Million | -1.57 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | 200 Thousand | 1.21 Million | 2.35 Million | -55 Thousand | - |
| Accounts receivables | 1.89 Million | 1.88 Million | -1.65 Million | -2.39 Million | 1.54 Million | -50 Thousand |
| Accounts payables | - | 526 Thousand | - | 2.21 Million | -3.08 Million | -172 Thousand |
| Inventory | -940 Thousand | -2.5 Million | 587 Thousand | -478 Thousand | 287 Thousand | 66 Thousand |
| Other working capital | -1.8 Million | 526 Thousand | -523 Thousand | 2.21 Million | -3.08 Million | -172 Thousand |
| Cash at beginning of period | 1.43 Million | 3.1 Million | 3.1 Million | 106 Thousand | 554 Thousand | 819 Thousand |
| Cash at end of period | 657 Thousand | 1.43 Million | 249 Thousand | 3.1 Million | 106 Thousand | 554 Thousand |
| Capital Expenditure | -2.6 Million | -2.05 Million | -3.34 Million | -904 Thousand | -718 Thousand | -993 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -780 Thousand | -1.67 Million | -2.85 Million | 3 Million | -448 Thousand | -265 Thousand |
| Free Cash Flow | 534 Thousand | 586 Thousand | -4.15 Million | 553 Thousand | 903 Thousand | 1.29 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.4 Million | 2.2 Million | 393 Thousand | 393 Thousand | 708 Thousand | 708 Thousand |
| Depreciation & Amortization | 921 Thousand | 1.7 Million | 405 Thousand | 405 Thousand | 446.5 Thousand | 446.5 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.42 Million | -856 Thousand | 992.5 Thousand | 992.5 Thousand | -1.42 Million | -1.42 Million |
| Other non-cash items | 206 Thousand | 92 Thousand | 28.5 Thousand | 28.5 Thousand | 17.5 Thousand | 17.5 Thousand |
| Investing Cash Flow | 1.21 Million | -2.01 Million | -757.5 Thousand | -757.5 Thousand | -251.5 Thousand | -251.5 Thousand |
| Investments in PPE | -513 Thousand | -2.6 Million | -889 Thousand | -889 Thousand | -414.5 Thousand | -414.5 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1.72 Million | 589 Thousand | 131.5 Thousand | 131.5 Thousand | 163 Thousand | 163 Thousand |
| Financing Cash Flow | -2.5 Million | -1.9 Million | -1.74 Million | -1.74 Million | 794 Thousand | 794 Thousand |
| Debt repayment | -2.47 Million | -1.9 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -26 Thousand | - | -1.74 Million | -1.74 Million | 794 Thousand | 794 Thousand |
| Accounts receivables | -237 Thousand | 1.89 Million | 1.48 Million | 1.48 Million | -541 Thousand | -541 Thousand |
| Accounts payables | 1.19 Million | - | - | - | - | - |
| Inventory | -2.38 Million | -940 Thousand | 1.39 Million | 1.39 Million | -1.86 Million | -1.86 Million |
| Other working capital | - | -1.8 Million | -1.88 Million | -1.88 Million | 982 Thousand | 982 Thousand |
| Cash at beginning of period | 3.03 Million | 1.43 Million | - | - | - | - |
| Cash at end of period | 470 Thousand | 657 Thousand | -684 Thousand | -684 Thousand | 294 Thousand | 294 Thousand |
| Capital Expenditure | -513 Thousand | -2.6 Million | -889 Thousand | -889 Thousand | -414.5 Thousand | -414.5 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.56 Million | -780 Thousand | -684 Thousand | -684 Thousand | 294 Thousand | 294 Thousand |
| Free Cash Flow | 592 Thousand | 534 Thousand | 930 Thousand | 930 Thousand | -663 Thousand | -663 Thousand |
SKGRW
SELX
KGKC
CHIF
2316
600258